Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID - PE
NCT06433011Recruiting
- Sponsor
- Thrombolex
- Start
- Oct 2024
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Open-label, single-arm trial in pulmonary embolism (PE), sponsored by Thrombolex. Primary endpoint: Death from any cause or hemodynamic decompensation (or collapse) at 7 days. Started Oct 2024; status: recruiting.
02
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT06433011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06433011.